⌘K
Loading ticker…
As of 2026-08-24, LENZ Therapeutics, Inc. Common Stock (LENZ) has a 3-month relative strength percentile of 10 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 29. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.8%, relative volume 0.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LENZ is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -15.6% / -62.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
LENZ is held by 15 ETFs as of May 2026. Top owner: SCHA at 0.00% weight, $809K notional. Top 3 carry $2M.
Held by 34 ETFs · $23M across latest filings · largest weight 0.79% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $809K | — |
| VTWO | 0.00% | $792K | — |
| VHTVanguard Health Care ETF | 0.00% | $271K | — |
| VTWG | 0.01% | $145K | — |
| IBBQ | 0.02% | $13K | −0.01 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $10K |
| — |
| BIB | 0.01% | $9K | — |
| ITWO | 0.00% | $7K | — |
| WSML | 0.00% | $7K | — |
| URTY | 0.00% | $6K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LENZ Jan avg: -6.35% median: -6.35% win: 0% σ: 7.38% n: 2 2024-03-25 → 2026-07-31 | LENZ Feb avg: -14.61% median: -14.61% win: 0% σ: 0.17% n: 2 2024-03-25 → 2026-07-31 | LENZ Mar avg: 7.81% median: 17.77% win: 67% σ: 36.05% n: 3 2024-03-25 → 2026-07-31 | LENZ Apr avg: -6.63% median: -1.86% win: 33% σ: 20.34% n: 3 2024-03-25 → 2026-07-31 | LENZ May avg: -4.87% median: -3.65% win: 33% σ: 7.95% n: 3 2024-03-25 → 2026-07-31 | LENZ Jun avg: -4.51% median: 0.38% win: 67% σ: 20.48% n: 3 2024-03-25 → 2026-07-31 | LENZ Jul avg: 12.83% median: 1.57% win: 67% σ: 26.97% n: 3 2024-03-25 → 2026-07-31 | LENZ Aug avg: 11.98% median: 11.98% win: 50% σ: 25.14% n: 2 2024-03-25 → 2026-07-31 (current) | LENZ Sep avg: 11.04% median: 11.04% win: 100% σ: 13.49% n: 2 2024-03-25 → 2026-07-31 | LENZ Oct avg: -11.32% median: -11.32% win: 50% σ: 35.19% n: 2 2024-03-25 → 2026-07-31 | LENZ Nov avg: 17.37% median: 17.37% win: 100% σ: 20.76% n: 2 2024-03-25 → 2026-07-31 | LENZ Dec avg: -33.24% median: -33.24% win: 0% σ: 20.27% n: 2 2024-03-25 → 2026-07-31 |